Traditional Chinese medicine has played a good part in the prevention and treatment of many diseases due to its low toxicity, effectiveness and ability to regulate the functions of the whole body from multiple targets. Traditional Chinese medicine compound can also play a synergistic effect between a variety of single-flavor Chinese medicines to act on multiple targets of the disease, and then achieve therapeutic effects. During recent years, many researchers have begun to concentrate on the pharmacological activity of traditional Chinese medicine, and clinical studies have also shown that the traditional Chinese medicine in the adjuvant treatment of AD is remarkable, and the development of effective drugs to improve the course of AD from natural herbs has become a hot spot in today’s research. Therefore, this article reviews the current status of traditional Chinese medicine in the treatment of AD, in order to provide new ideas for related research.
FerrariCSorbiS. The complexity of Alzheimer’s disease: an evolving puzzle. Physiol Rev2021; 101(3): 1047–1081.
2.
KhanSBarveKHKumarMS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease. Curr Neuropharmacol2020; 18(11): 1106–1125.
3.
TiwariSAtluriVKaushikA, et al.Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomed2019; 14: 5541–5554.
4.
YuTWLaneHYLinCH. Novel therapeutic approaches for Alzheimer’s disease: an updated review. Int J Mol Sci2021; 22(15): 8208.
5.
ScheltensPDe StrooperBKivipeltoM, et al.Alzheimer’s disease. Lancet (London, England)2021; 397(10284): 1577–1590.
6.
Guzman-MartinezLCalfíoCFariasGA, et al.New frontiers in the prevention, diagnosis, and treatment of Alzheimer’s disease. J Alzheimers Dis2021; 82(s1): S51–s63.
7.
ChenSYGaoYSunJY, et al.Traditional Chinese medicine: role in reducing β-amyloid, apoptosis, autophagy, neuroinflammation, oxidative stress, and mitochondrial dysfunction of Alzheimer's disease. Front Pharmacol2020; 11: 497.
8.
DengCChenHMengZ, et al.Roles of traditional Chinese medicine regulating neuroendocrinology on AD treatment. Front Endocrinol2022; 13: 955618.
9.
AroraABehlTSehgalA, et al.Elucidating the promising role of traditional Chinese medicine in neuroprotection against oxidative stress encompassing Alzheimer’s disease. Environ Sci Pollut Res Int2023; 30(14): 39546–39557.
10.
Alzheimer’s disease facts and figures. Alzheimers Dement2021; 17(3): 327–406.
11.
PohankaM. Inhibitors of cholinesterases in pharmacology: the current trends. Mini Rev Med Chem2020; 20(15): 1532–1542.
12.
ZhongWLiuXVossT, et al.Medications in patients with dementia and behavioral disturbance. J Alzheimers Dis Rep2021; 5(1): 535–540.
13.
VejandlaBSavaniSAppalaneniR, et al.Alzheimer’s disease: the past, present, and future of a globally progressive disease. Cureus2024; 16(1): e51705.
14.
TsoiKKChanJYChanFC, et al.Monotherapy is good enough for patients with mild-to-moderate Alzheimer’s disease: a network meta-analysis of 76 randomized controlled trials. Clin Pharmacol Ther2019; 105(1): 121–130.
JeremicDJiménez-DíazLNavarro-LópezJD. Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review. Ageing Res Rev2021; 72: 101496.
17.
PeiHMaLCaoY, et al.Traditional Chinese medicine for Alzheimer’s disease and other cognitive impairment: a review. Am J Chin Med2020; 48(3): 487–511.
18.
WangXC. Effect of astragaloside IV on Aβ (1-42)-induced Alzheimer disease-like phenotype and its mechanism. Hefei: Anhui Medical University, 2020.
19.
QuWYXieJGLiangAX. Effects of astragalus polysaccharides on activity, cognitive function and expression of Caspase-9 in neurons of rats with Alzheimer’s disease. Stroke and Neurological Disorders2021.
20.
HuangXLiNPuY, et al.Neuroprotective effects of ginseng phytochemicals: recent perspectives. Molecules2019; 24(16): 2939.
21.
RazgonovaMPVeselovVVZakharenkoAM, et al.Panax ginseng components and the pathogenesis of Alzheimer's disease. Mol Med Rep2019; 19(4): 2975–2998, (Review).
22.
SunYLiuZPiZ, et al.Poria cocos could ameliorate cognitive dysfunction in APP/PS1 mice by restoring imbalance of Aβ production and clearance and gut microbiota dysbiosis. Phytother Res2021; 35(5): 2678–2690.
23.
ZhangYWuYFuY, et al.Anti-Alzheimer’s disease molecular mechanism of acori tatarinowii rhizoma based on network pharmacology. Med Sci Monit Basic Res2020; 26: e924203.
24.
ChenXYLiaoDCSunML, et al.Essential oil of acorus tatarinowii schott ameliorates aβ-induced toxicity in Caenorhabditis elegans through an autophagy pathway. Oxid Med Cell Longev2020; 2020: 3515609.
25.
SinghSKSrivastavSCastellaniRJ, et al.Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics2019; 16(3): 666–674.
26.
ZhengYXieYQiM, et al.Ginkgo biloba extract is comparable with donepezil in improving functional recovery in Alzheimer's disease: results from a multilevel characterized study based on clinical features and resting-state functional magnetic resonance imaging. Front Pharmacol2021; 12: 721216.
27.
FuHXuZZhangXL, et al.Kaixinsan, a well-known Chinese herbal prescription, for Alzheimer's disease and depression: a preclinical systematic review. Front Neurosci2019; 13: 1421.
28.
LuoYLiDLiaoY, et al.Systems pharmacology approach to investigate the mechanism of kai-xin-san in Alzheimer's disease. Front Pharmacol2020; 11: 381.
29.
GaoHLZhangAHYuJB, et al.High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer’s disease in APP/PS1 transgenic mice. J Chromatogr B Analyt Technol Biomed Life Sci2018; 1092: 286–295.
30.
OngWYWuYJFarooquiT, et al.Qi fu yin-a ming dynasty prescription for the treatment of dementia. Mol Neurobiol2018; 55(9): 7389–7400.
31.
NgoFYWangWChenQ, et al.Network pharmacology analysis and molecular characterization of the herbal medicine formulation qi-fu-yin for the inhibition of the neuroinflammatory biomarker iNOS in microglial BV-2 cells: implication for the treatment of Alzheimer's disease. Oxid Med Cell Longev2020; 2020: 5780703.
32.
WuFTianZHPengJX. The pharmacological mechanism of Qifuyin in the treatment of senile dementia based on network. Pharmacology2020; 18(13): 2059–2062.
33.
YangCMoYSChenHF, et al.The effects of Danggui-Shaoyao-San on neuronal degeneration and amyloidosis in mouse and its molecular mechanism for the treatment of Alzheimer’s disease. J Integr Neurosci2021; 20(2): 255–264.
34.
LiuPZhouXZhangH, et al.Danggui-shaoyao-san attenuates cognitive impairment via the microbiota-gut-brain Axis with regulation of lipid metabolism in scopolamine-induced amnesia. Front Immunol2022; 13: 796542.
35.
WuWHeXXieS, et al.Protective effects of Huang-Lian-Jie-Du-Tang against Aβ(25-35)-induced memory deficits and oxidative stress in rats. J Int Med Res2020; 48(3): 300060519893859.
36.
ZengQLiLSiuW, et al.A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease. Biomed Pharmacother2019; 120: 109370.
37.
CummingsJLTongGBallardC. Treatment combinations for Alzheimer's disease: current and future pharmacotherapy options. J Alzheimers Dis2019; 67(3): 779–794.
38.
YinWLvGLiC, et al.Acupuncture therapy for Alzheimer's disease: the effectiveness and potential mechanisms. Anat Rec2021; 304(11): 2397–2411.
39.
HuangRWuFZhaoJ, et al.[Electroacupuncture plus gastrodin improves learning-memory ability possibly by up-regulating expression of SIRT 1 and PGC-1 ɑ in hippocampal CA 1 region of Alzheimer's disease rats]. Zhen Ci Yan Jiu2018; 43(3): 140–145.
